Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	1415823-73-2
Formula :	C₂₅H₂₇N₅O₂
M.W :	429.51
SMILES Code :	C=CC(N1CCC(CNC2=NC=NC(N)=C2C3=CC=C(OC4=CC=CC=C4)C=C3)CC1)=O
Synonyms :	M-2951; MSC-2364447C; M2951
MDL No. :	MFCD30502975
InChI Key :	QUIWHXQETADMGN-UHFFFAOYSA-N
Pubchem ID :	71479709

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

U937 NF-κB–Luc reporter cells	5 nM to 10 µM	30 minutes	Inhibition of FcγR signaling	J Immunol. 2019 May 15;202(10):2888-2906.
BTK	2 µM	10 min	To validate the labeling efficiency of evobrutinib derivatives on BTK	J Am Chem Soc. 2021 Dec 8;143(48):20095-20108.
Healthy donor CD27- naive B cells	1 µM	11 days	To study the effect of Evobrutinib on the differentiation of naive B cells into T-bet+ class-switched memory B cells, results showed that Evobrutinib diminished T-bet induction and class switching.	JCI Insight. 2022 Aug 22;7(16):e160909.
HMC3 cells	10 µM	12 hours	BTK inhibition downregulated genes involved in microglial activation and cytokine release, including TLR4, NFKB1, RELA, NLRP3, IL6, and IL1B, while upregulating the microglial quiescence marker P2RY12. Additionally, BTK inhibition reduced the expression of iron-related genes TIM1, LRP1, DMT1, HAMP, and FTL, and increased the expression of the iron exporter FPN.	Brain Pathol. 2024 Sep;34(5):e13240.
Jurkat cells	500 nM	2 hours	Evaluate the labeling efficacy of Evo-2 in Jurkat cells, showing no BTK expression in Jurkat cells.	RSC Chem Biol. 2025 Feb 20;6(4):618-629.
Ramos cells	500 nM	2 hours	Evaluate the labeling efficacy of Evo-2 in Ramos cells, showing effective labeling of endogenous BTK.	RSC Chem Biol. 2025 Feb 20;6(4):618-629.
Ramos B cells	0, 0.01, 0.1, 1, 10, 100, 1000 μg/mL	30 minutes	Inhibition of BTK autophosphorylation after BCR activation	J Immunol. 2019 May 15;202(10):2888-2906.
T cells	1 µM	30 minutes	To assess the effect of Evobrutinib on T cell activation, results showed that Evobrutinib had no inhibitory effect on calcium mobilization in T cells.	Acta Neuropathol. 2020 Oct;140(4):535-548.
B cells	1 µM	30 minutes	To assess the effect of Evobrutinib on BCR-mediated B cell activation, results showed that Evobrutinib strongly inhibited intracellular calcium mobilization upon BCR ligation via anti-IgM.	Acta Neuropathol. 2020 Oct;140(4):535-548.
Healthy donor peripheral blood B cells	1 µM	48 hours	To study the effect of Evobrutinib on IFN-γ and CpG-ODN-induced T-bet expression, results showed that Evobrutinib attenuated the upregulation of T-bet.	JCI Insight. 2022 Aug 22;7(16):e160909.
Healthy donor CD27+ memory B cells	1 µM	6 days	To study the effect of Evobrutinib on the differentiation of memory B cells into antibody-secreting cells (ASCs), results showed that Evobrutinib reduced ASC formation and IgG secretion.	JCI Insight. 2022 Aug 22;7(16):e160909.
PBMCs	0, 0.01, 0.1, 1, 10, 100, 1000 μg/mL	60 minutes	Inhibition of B cell activation	J Immunol. 2019 May 15;202(10):2888-2906.
HER2-negative breast cancer cell lines (MCF7, T47D, BT20, HCC1806)	>5 µM (GI50)	72 hours	Evaluate the antiproliferative effect of Evobrutinib on HER2-negative breast cancer cell lines, results showed no significant activity of Evobrutinib in these cell lines	Invest New Drugs. 2023 Apr;41(2):210-219.
HER2-positive breast cancer cell lines (BT474, SKBR3, AU565, EFM192A)	>5 µM (GI50)	72 hours	Evaluate the antiproliferative effect of Evobrutinib on HER2-positive breast cancer cell lines, results showed no significant activity of Evobrutinib in these cell lines	Invest New Drugs. 2023 Apr;41(2):210-219.

Mice	Collagen-induced arthritis (CIA) model	Oral	1 mg/kg, 3 mg/kg	Once daily for 15 days	Evaluation of Evobrutinib efficacy in RA model	J Immunol. 2019 May 15;202(10):2888-2906.
C57BL/6 mice	Experimental autoimmune encephalomyelitis (EAE)	Oral	1, 3, or 10 mg/kg	Once daily for 7 days	To assess the clinical and histological effects of Evobrutinib on EAE, results showed that Evobrutinib dose-dependently ameliorated clinical and histological EAE.	Acta Neuropathol. 2020 Oct;140(4):535-548.
Mice (C57BL/6J and SJL/J)	Experimental autoimmune encephalomyelitis (EAE) model and cuprizone model of toxic de- and remyelination	Oral gavage	10 mg/kg	Daily for 14–41 days	Evaluated the therapeutic effects of Evobrutinib in EAE and demyelination models, showing that Evobrutinib ameliorated clinical severity of EAE, reduced pro-inflammatory activation of microglia, and promoted clearance of myelin debris and remyelination.	Acta Neuropathol. 2024 Apr 24;147(1):75
SJL/J mice	Experimental autoimmune encephalomyelitis (EAE)	Oral gavage	10 mg/kg	Once daily for 4 weeks	To evaluate the effect of Evobrutinib on established meningeal inflammation. Results showed a significant reduction in meningeal contrast enhancement in the evobrutinib group compared to vehicle (30% reduction versus 5% increase; P=0.003).	Brain. 2021 Jun 22;144(5):1396-1408

{[proInfo.proName]}

CAS No.: 1415823-73-2

{[proInfo.proName]}

CAS No.: 1415823-73-2

Alternative Products

Product Details of Evobrutinib

Safety of Evobrutinib

Related Pathways of Evobrutinib

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT03436394	Renal Impairment	PHASE1	COMPLETED	2019-02-22	Please Contact the Merck KGaA ... More >>Communication Center, Darmstadt, 64293, Germany Less <<
NCT03725072	Healthy	PHASE1	COMPLETED	2018-12-05	PRA Health Sciences, Groningen... More >>, 9728 NZ, Netherlands Less <<
NCT04314024	Healthy	PHASE1	COMPLETED	2020-06-23	Nuvisan GmbH, Neu-Ulm, Germany
NCT03934502	Healthy	PHASE1	COMPLETED	2019-06-12	Nuvisan GmbH, Neu-Ulm, 89231, ... More >>Germany Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.33mL 0.47mL 0.23mL	11.64mL 2.33mL 1.16mL	23.28mL 4.66mL 2.33mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed